[go: up one dir, main page]

ZA966617B - New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters). - Google Patents

New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).

Info

Publication number
ZA966617B
ZA966617B ZA9606617A ZA966617A ZA966617B ZA 966617 B ZA966617 B ZA 966617B ZA 9606617 A ZA9606617 A ZA 9606617A ZA 966617 A ZA966617 A ZA 966617A ZA 966617 B ZA966617 B ZA 966617B
Authority
ZA
South Africa
Prior art keywords
thioesters
acyl
pct
new methods
acid ester
Prior art date
Application number
ZA9606617A
Other languages
English (en)
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA966617B publication Critical patent/ZA966617B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9606617A 1995-08-04 1996-08-02 New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters). ZA966617B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
ZA966617B true ZA966617B (en) 1997-02-18

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606617A ZA966617B (en) 1995-08-04 1996-08-02 New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).

Country Status (27)

Country Link
US (1) US6117909A (pt)
EP (1) EP0841913B1 (pt)
JP (1) JPH11510184A (pt)
KR (1) KR19990036127A (pt)
CN (1) CN1192140A (pt)
AT (1) ATE232097T1 (pt)
AU (1) AU716255B2 (pt)
BG (1) BG63863B1 (pt)
CA (1) CA2221729A1 (pt)
CZ (1) CZ26198A3 (pt)
DE (1) DE69626118T2 (pt)
DK (1) DK0841913T3 (pt)
EA (1) EA002435B1 (pt)
EE (1) EE9800037A (pt)
ES (1) ES2191762T3 (pt)
GE (1) GEP20012511B (pt)
HR (1) HRP960341A2 (pt)
HU (1) HUP9900668A3 (pt)
IL (1) IL122247A0 (pt)
NO (1) NO980466D0 (pt)
NZ (1) NZ312571A (pt)
PL (1) PL185943B1 (pt)
PT (1) PT841913E (pt)
SK (1) SK12598A3 (pt)
UA (1) UA46030C2 (pt)
WO (1) WO1997005868A1 (pt)
ZA (1) ZA966617B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
TR200100205T2 (tr) * 1998-07-21 2001-05-21 Warner-Lambert Company Aterosklerotik lezyonların tedavisi için ACAT ve MMP inhibitörlerinin birlikte uygulanması.
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
KR20020050257A (ko) * 1999-11-05 2002-06-26 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Ａｃａｔ 저해제에 의한 플라크 파열의 방지
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
JP7269928B2 (ja) 2017-11-14 2023-05-09 メルク・シャープ・アンド・ドーム・エルエルシー インドールアミン ２，３－ジオキシゲナーゼ（ｉｄｏ）阻害剤としての新規の置換ビアリール化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
ATE116291T1 (de) * 1990-10-30 1995-01-15 Warner Lambert Co Oxysulfonylcarbamate.
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
UA46030C2 (uk) 2002-05-15
EA002435B1 (ru) 2002-04-25
NZ312571A (en) 2000-07-28
IL122247A0 (en) 1998-04-05
DE69626118D1 (de) 2003-03-13
ATE232097T1 (de) 2003-02-15
HRP960341A2 (en) 1998-02-28
KR19990036127A (ko) 1999-05-25
BG63863B1 (bg) 2003-04-30
GEP20012511B (en) 2001-08-27
EA199800176A1 (ru) 1998-10-29
ES2191762T3 (es) 2003-09-16
EE9800037A (et) 1998-08-17
HUP9900668A2 (hu) 1999-06-28
WO1997005868A1 (en) 1997-02-20
JPH11510184A (ja) 1999-09-07
AU716255B2 (en) 2000-02-24
CN1192140A (zh) 1998-09-02
PL324908A1 (en) 1998-06-22
EP0841913B1 (en) 2003-02-05
EP0841913A1 (en) 1998-05-20
SK12598A3 (en) 1999-02-11
DK0841913T3 (da) 2003-05-05
PT841913E (pt) 2003-06-30
PL185943B1 (pl) 2003-09-30
AU6454196A (en) 1997-03-05
HUP9900668A3 (en) 2000-08-28
NO980466L (no) 1998-02-03
CA2221729A1 (en) 1997-02-20
CZ26198A3 (cs) 1998-07-15
NO980466D0 (no) 1998-02-03
DE69626118T2 (de) 2003-11-27
US6117909A (en) 2000-09-12
BG102222A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
GR3030356T3 (en) N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
ZA966617B (en) New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).
PE46799A1 (es) Aminofosfonatos sustituidos con grupos fenolicos y piridina
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ATE187461T1 (de) Cyklopeptolide
DE69005974D1 (de) Heteroaryl-3-oxo-propannitril-derivate, nützlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
DE69616357D1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE59407547D1 (de) Verfahren zur Herstellung von 2-substituierten 5-Chlorimidazol-4-carbaldehyden
ATE315575T1 (de) Immunopotenzierende 5'-nucleotidase-resistente inosinmonophosphat-derivate und ihre verwendung